Yung Shin Pharm Company Profile
✉ Email this page to a colleague
What is the competitive landscape for YUNG SHIN PHARM
YUNG SHIN PHARM has eleven approved drugs.
Drugs and US Patents for Yung Shin Pharm
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Yung Shin Pharm | GRANISETRON HYDROCHLORIDE | granisetron hydrochloride | INJECTABLE;INJECTION | 202648-001 | Jun 29, 2020 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Yung Shin Pharm | CEFACLOR | cefaclor | FOR SUSPENSION;ORAL | 065412-004 | Feb 17, 2012 | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | |||||
| Yung Shin Pharm | DICLOFENAC SODIUM AND MISOPROSTOL | diclofenac sodium; misoprostol | TABLET, DELAYED RELEASE;ORAL | 205143-001 | Feb 19, 2020 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Yung Shin Pharm | ZOLPIDEM TARTRATE | zolpidem tartrate | TABLET;ORAL | 077990-001 | Apr 23, 2007 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Yung Shin Pharm | FELODIPINE | felodipine | TABLET, EXTENDED RELEASE;ORAL | 204800-002 | Apr 29, 2019 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Yung Shin Pharm | CEPHALEXIN | cephalexin | FOR SUSPENSION;ORAL | 065336-001 | Jul 25, 2007 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Yung Shin Pharm | CLONIDINE HYDROCHLORIDE | clonidine hydrochloride | TABLET;ORAL | 202297-002 | Jun 13, 2013 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

